gempex and msg industry advisors cooperate in the field of AI-supported services in the GMP-regulated environment
Quality assurance more efficient, targeted and secure
Advertisement
artificial intelligence (AI) is powerfully conquering all segments of industry. This also applies to the regulated life sciences sector, where high demands are placed on reliability and quality.
Symbolic image
AI-generated image
gempex and msg industry advisors are pooling their expertise here to offer well-founded, groundbreaking solutions with leading expertise in the areas of IT application, process and GxP regulations. The aim is to provide consulting and implementation services in the highly regulated pharmaceutical environment with a focus on GxP compliance with the use of AI-driven tools in a more efficient, targeted and high-quality manner.
"With the help of AI, immense savings potential can already be seen in the GMP consulting sector - which benefits customers" - says Ralf Gengenbach, founder and Managing Director of gempex GmbH. In addition to the speed with which tasks can be processed with the help of tools, Gengenbach also emphasizes the level of quality, which can be significantly increased with the help of AI.
"With the abundance of documents required in quality assurance in the GMP environment, it is hardly possible for people to work without contradictions or overlaps. This is exactly where AI comes in to eliminate these redundancies and contradictions and to streamline the documentation," Gengenbach continues.
And security with regard to sensitive information? This is exactly where the intention of the cooperation comes in. msg industry advisors brings all the necessary knowledge to be able to use such systems safely without compromising performance. The community will soon enter the market with its own solutions.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Tacalyx appoints Jean Engela as Chief Executive Officer for the next phase of growth
NextPharma sells its logistics division to Cencora - The sale is part of the plan to position NextPharma as Europe's leading pure-play CDMO.
How an Invisible “Cap” could control Electrical Synapses - New Building Blocks of Cell Communication
A new tunable cell-sorting device with potential biomedical applications - Precise, label-free sorting of cells of various sizes possible due to a temperature-sensitive PNIPAM hydrogel array
Proteins in a crowd: European XFEL looks inside cells - Researchers observe in detail how the vital iron protein ferritin makes its way in highly dense environments
The smell of fatty foods during pregnancy promotes obesity in offspring - The brains of the offspring show similarities to those of obese adult mice
Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions - Collaboration combines complementary scientific and technical expertise to provide seamless solutions along the entire biopharmaceutical value chain
The power of gut enzymes: why a healthy diet works differently for everyone
Intelligent hydrogel microstructures enable the precise application of force to cellular systems